Zhenyu Duan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhenyu Duan has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Gang Xu
Department of Radiology, Huaxi MR Research Center (HMRRC), Institution of Radiology and Medical Imaging, Liver Transplant Center, Organ Transplant Center West China Hospital Sichuan University Chengdu China
1 shared publicationHao Chen
Department of Radiology, Huaxi MR Research Center (HMRRC), Institution of Radiology and Medical Imaging, Liver Transplant Center, Organ Transplant Center West China Hospital Sichuan University Chengdu China
1 shared publicationJiayin Yang
Department of Radiology, Huaxi MR Research Center (HMRRC), Institution of Radiology and Medical Imaging, Liver Transplant Center, Organ Transplant Center West China Hospital Sichuan University Chengdu China
1 shared publicationLingxiao Yang
Department of Radiology, Huaxi MR Research Center (HMRRC), Institution of Radiology and Medical Imaging, Liver Transplant Center, Organ Transplant Center West China Hospital Sichuan University Chengdu China
1 shared publicationQingyi Wang
State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology Sichuan University Chengdu China
1 shared publicationWen Wen
State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology Sichuan University Chengdu China
1 shared publication
Latest Publications
- Open Access
- 23 March 2025
- Published by Wiley in MedComm – Future Medicine
- Vol. 4 (1)
Stem Cell‐Derived Exosomes as Nanotherapeutics for Inflammatory Diseases
Inflammation, as a complex biological response, can lead to tissue damage and pathological physiological changes, forming the basis for many chronic diseases. Stem cell‐derived exosomes (SC‐Exos), a type of nanoscale extracellular vesicle, possess advantages such as small volume, low immunogenicity, and drug‐carrying capacity, demonstrating immense potential in the field of disease diagnostics and therapeutics. Current studies indicate that SC‐Exos can not only alleviate inflammatory diseases by suppressing inflammatory cytokines and modulating the activation of macrophages through their immunomodulatory and regenerative properties but also show significant potential as carriers for anti‐inflammatory drugs, presenting a promising therapeutic approach for inflammatory conditions. However, the current lack of systematic summaries of SC‐Exos in the treatment of inflammatory diseases has impeded the development of standardized therapies and clinical applications. This review elucidates the methods of SC‐Exo sourcing, isolation, characterization, and engineering, as well as their application, mechanisms of action, and efficacy in the treatment of inflammatory diseases such as periodontitis, osteoarthritis (OA), and inflammatory bowel disease. Integrating these findings, this review highlights that SC‐Exos can attenuate a variety of inflammatory diseases by transporting a diverse range of molecules to modulate immune responses, thereby providing foundations for subsequent standardization of production and clinical trials.
- 23 March 2025
- Published by Wiley in MedComm – Future Medicine
- Vol. 4 (1)
Open AccessStem Cell‐Derived Exosomes as Nanotherapeutics for Inflammatory Diseases
Inflammation, as a complex biological response, can lead to tissue damage and pathological physiological changes, forming the basis for many chronic diseases. Stem cell‐derived exosomes (SC‐Exos), a type of nanoscale extracellular vesicle, possess advantages such as small volume, low immunogenicity, and drug‐carrying capacity, demonstrating immense potential in the field of disease diagnostics and therapeutics. Current studies indicate that SC‐Exos can not only alleviate inflammatory diseases by suppressing inflammatory cytokines and modulating the activation of macrophages through their immunomodulatory and regenerative properties but also show significant potential as carriers for anti‐inflammatory drugs, presenting a promising therapeutic approach for inflammatory conditions. However, the current lack of systematic summaries of SC‐Exos in the treatment of inflammatory diseases has impeded the development of standardized therapies and clinical applications. This review elucidates the methods of SC‐Exo sourcing, isolation, characterization, and engineering, as well as their application, mechanisms of action, and efficacy in the treatment of inflammatory diseases such as periodontitis, osteoarthritis (OA), and inflammatory bowel disease. Integrating these findings, this review highlights that SC‐Exos can attenuate a variety of inflammatory diseases by transporting a diverse range of molecules to modulate immune responses, thereby providing foundations for subsequent standardization of production and clinical trials.